Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia
- PMID: 12787858
- DOI: 10.1016/S0278-5846(03)00080-0
Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia
Abstract
It was investigated whether subchronic application of 30 mg/kg ketamine (Ket) induces reliable changes in behaviour and parameters of dopaminergic, glutamatergic, and serotonergic neurotransmissions, which might be the basis of an animal model in schizophrenia research. To test this, rats were injected with 30 mg/kg ip Ket daily for five consecutive days. In response to the first Ket injection, there was a decrease in activity time representing an acute Ket effect. Following the fifth injection, there were no differences between Ket- and saline (sal)-injected control rats in activity time, which might be a tolerance reaction. The following experiments were performed 2 or 4 weeks after Ket treatment. There were no effects on anxiety in either vehicle or Ket-treated rats using either low or high illumination levels in the elevated plus-maze. In the social interaction test, both groups of rats spent comparable times in social contact. The percentage of nonaggressive behaviour was decreased in Ket-treated rats. Two weeks after completion of the treatment, there was no effect on prepulse inhibition (PPI). Four weeks after the final Ket injection, latent inhibition (LI) was disrupted. There was no difference in the animals' activity in reaction to apomorphine (Apo) administration. Ket-treated rats injected with 0.1 mg/kg MK-801 showed an enhancement in locomotor activity. Ket treatment leads to an increase in D2 receptor binding in the hippocampus and a decrease in glutamate receptor binding in the frontal cortex. The authors did not find any changes in D1 receptor binding. The density of dopamine transporters was increased in the striatum. The density of 5-HT transporters was increased in the striatum, the hippocampus, and the frontal cortex. The results suggest that subchronic treatment with subanaesthetic doses of Ket induce schizophrenia-related alterations, which might be a useful animal model in the study of this disease.
Similar articles
-
Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity.Prog Neuropsychopharmacol Biol Psychiatry. 2004 Dec;28(8):1267-77. doi: 10.1016/j.pnpbp.2004.06.019. Prog Neuropsychopharmacol Biol Psychiatry. 2004. PMID: 15588753
-
Neonatal NMDA receptor antagonist treatments have no effects on prepulse inhibition of postnatal day 25 Sprague-Dawley rats.Neurotoxicology. 2009 Jan;30(1):151-4. doi: 10.1016/j.neuro.2008.10.011. Epub 2008 Nov 7. Neurotoxicology. 2009. PMID: 19038286
-
Pain sensitivity is altered in animals after subchronic ketamine treatment.Psychopharmacology (Berl). 2006 Dec;189(2):237-47. doi: 10.1007/s00213-006-0557-2. Epub 2006 Oct 3. Psychopharmacology (Berl). 2006. PMID: 17016710
-
The neurobiology of cognition in schizophrenia.J Clin Psychiatry. 2006;67 Suppl 9:9-13; discussion 36-42. J Clin Psychiatry. 2006. PMID: 16965183 Review.
-
Ketamine as a street drug.Emerg Med Serv. 2001 Nov;30(11):30, 32, 34 passim. Emerg Med Serv. 2001. PMID: 11759641 Review.
Cited by
-
Ketamine-Treatment During Late Adolescence Impairs Inhibitory Synaptic Transmission in the Prefrontal Cortex and Working Memory in Adult Rats.Front Cell Neurosci. 2019 Aug 20;13:372. doi: 10.3389/fncel.2019.00372. eCollection 2019. Front Cell Neurosci. 2019. PMID: 31481877 Free PMC article.
-
A Postsynaptic Density Immediate Early Gene-Based Connectome Analysis of Acute NMDAR Blockade and Reversal Effect of Antipsychotic Administration.Int J Mol Sci. 2023 Feb 22;24(5):4372. doi: 10.3390/ijms24054372. Int J Mol Sci. 2023. PMID: 36901803 Free PMC article.
-
Risperidone and haloperidol promote survival of stem cells in the rat hippocampus.Eur Arch Psychiatry Clin Neurosci. 2010 Mar;260(2):151-62. doi: 10.1007/s00406-009-0033-1. Epub 2009 Jul 5. Eur Arch Psychiatry Clin Neurosci. 2010. PMID: 19579000
-
Profiling the psychotic, depressive and anxiety symptoms in chronic ketamine users.Psychiatry Res. 2016 Mar 30;237:311-5. doi: 10.1016/j.psychres.2016.01.023. Epub 2016 Jan 14. Psychiatry Res. 2016. PMID: 26805565 Free PMC article.
-
Brain damages in ketamine addicts as revealed by magnetic resonance imaging.Front Neuroanat. 2013 Jul 17;7:23. doi: 10.3389/fnana.2013.00023. eCollection 2013. Front Neuroanat. 2013. PMID: 23882190 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical